top of page
.jpeg)
Daanish Jamal is the Founder and CEO of Dolmite Therapeutics Inc. Jamal is also a Georgetown alumnus and previously an Entpreneuer-in-Residence at SR One. Dolomite Therapeutics works to develop biologic degraders that induce durable remission in patients with autoimmune kidney disease.
bottom of page